3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Vasculitis, Central Nervous System
1
Stiff-Person Syndrome
1
Rasmussen subacute encephalitis
1
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
1
Plasmablastic Lymphoma
1
Opsoclonus-Myoclonus Syndrome
1
Neuromyelitis Optica
1
Myasthenia Gravis
1
Lymphoma, T-Cell
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Follicular
1
Lambert-Eaton Myasthenic Syndrome
1
Hodgkin Disease
1
HIV Infections
1
Burkitt Lymphoma
1
Brain Neoplasms
1
Autoimmune Diseases of the Nervous System
1
Autoimmune Diseases
1
Interventions
fludarabine phosphate
2
Whole-Body Irradiation
2
Tacrolimus
2
Peripheral Blood Stem Cell Transplantation
2
Mycophenolic Acid
2
Cyclophosphamide
2
Busulfan
2
fludarabine
1
Valganciclovir
1
Transplantation
1
Therapeutics
1
Sirolimus
1
Radiotherapy
1
Positron-Emission Tomography
1
Polymerase Chain Reaction
1
Methotrexate
1
Melphalan
1
Ganciclovir
1
Foscarnet
1
Flow Cytometry
1
Etoposide
1
Cyclosporine
1
Antiviral Agents
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Pdgfra-Associated Chronic Eosinophilic Leukemia
×
carmustine, poliferprosan 20 drug combination
×
1 year
×
Clear all
No trials found.